MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s0140-6736(26)01426-1

Медицинская библиотека · Lancet (London, England) · 2026

Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.

Silvain Johanne, Choi Ki Hong, Monguillon Victorien, Kang Danbee, Cayla Guillaume, Kim Weon, Ferrari Emile, Song Young Bin, Range Grégoire, Puymirat Etienne, Doh Joon-Hyung, Delarche Nicolas, Kim Juhan, Guedeney Paul, Park Yong Hwan, Diallo Abdourahmane, Ahn Sung Gyun, Vicaut Eric, Montalescot Gilles, Hahn Joo-Yong, ABYSS and SMART-DECISION investigators

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Many stable patients with chronic coronary syndrome continue β-blocker therapy for years after a myocardial infarction, despite having no clear ongoing indication. Whether β-blockers can be safely discontinued in such patients remains uncertain. The objective of this analysis was to assess the non-inferiority of β-blocker discontinuation versus continuation in patients with previous myocardial infarction and no remaining indication.

METHODS

We performed a pooled analysis of individual patient data from the ABYSS and SMART-DECISION randomised trials in stable patients over 6 months after a myocardial infarction with a left ventricular ejection fraction of ≥40% and no heart failure. Non-inferiority was assessed for the composite primary endpoint of all-cause death, myocardial infarction, stroke, or hospitalisation for cardiovascular reasons, and for the key secondary endpoint of all-cause death, myocardial infarction, or hospitalisation for heart failure. Analyses used a one-stage mixed-effects Cox proportional hazards model including trial as a random effect with margins of 1·25 for the primary endpoint and 1·40 for the key secondary endpoint. The review protocol was registered with PROSPERO, number CRD420261299839.

FINDINGS: Among 6238 patients (3698 from ABYSS and 2540 from SMART-DECISION), 3092 were assigned to β-blocker discontinuation and 3146 to continuation. Median time from index myocardial infarction to randomisation was 3·6 years (IQR 1·6-7·5) and median follow-up was 3·0 years (2·3-3·8). The primary endpoint occurred in 532 (17·2%) of 3092 patients in the β-blocker discontinuation group and 500 (15·9%) of 3146 in the continuation group (hazard ratio 1·09 [95% CI 0·97-1·24]; pnon-inferiority=0·016). The key secondary endpoint occurred in 201 (6·5%) of 3092 patients in the discontinuation group and 201 (6·4%) of 3146 patients in the continuation group (1·01 [0·83-1·23]; pnon-inferiority=0·0006). Findings were consistent irrespective of background left ventricular ejection fraction.

INTERPRETATION: In stable patients with previous myocardial infarction, left ventricular ejection fraction ≥40%, no heart failure, and no other indication for β-blocker therapy, discontinuation met the non-inferiority criteria for the primary and key secondary endpoints. Interpretation of the primary endpoint is limited by its hospitalisation-heavy and trial-dependent composition.

FUNDING: None.

Для цитирования: Silvain Johanne, Choi Ki Hong, Monguillon Victorien, Kang Danbee, Cayla Guillaume, Kim Weon, Ferrari Emile, Song Young Bin, Range Grégoire, Puymirat Etienne, Doh Joon-Hyung, Delarche Nicolas, Kim Juhan, Guedeney Paul, Park Yong Hwan, Diallo Abdourahmane, Ahn Sung Gyun, Vicaut Eric, Montalescot Gilles, Hahn Joo-Yong, ABYSS and SMART-DECISION investigators. Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.. Lancet (London, England). 2026. DOI: 10.1016/s0140-6736(26)01426-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.